Diagnostic Imaging’s Weekly Scan: May 24 — May 30

Welcome to Diagnostic Imaging’s Weekly Scan, which offers an opportunity to catch up on the most well-viewed radiology content of the past week.

In recent interviews with Diagnostic Imaging, Emanuel Kanal, MD, and Tobias Gilk, MRSO, MRSE, discuss new multicenter research examining pediatric MRI safety as well as key challenges and preventive measures in this patient population.

After the U.S. Preventive Services Task Force (USPSTF) updated its biennial mammography screening recommendations to begin at 40 years of age, women in their 40s accounted for approximately 50 percent of all screening mammography exams, according to new study findings presented at the American Society of Clinical Oncology (ASCO) conference.

In his latest blog for Diagnostic Imaging, Filippo Cademartiri, MD, PhD, discusses emerging CCTA research that affirms the importance of going beyond LDL reduction in the evaluation and treatment of patients with chronic coronary syndrome.

Earlier this week, Philips announced a new collaboration with the Walt Disney Company to integrate Disney characters into the Philips Ambient Experience platform into pediatric MRI exams for Philips MRI systems in 87 countries. In an interview with Diagnostic Imaging, Atul Gupta, MD, the chief medical officer for diagnosis and treatment at Philips, discussed clinically driven design parameters of this Disney character integration that have demonstrated a 43 percent reduction in anxiety level for children under 10 undergoing an MRI exam.

The Food and Drug Administration (FDA) granted 510(k) clearance for the SubtleHD(PET) software, which may allow up to a 75 percent improvement in scan times for positron emission tomography (PET). Other key attributes with the AI-powered software reportedly include enhanced image quality, improved SUVmax quantitative accuracy and compatibility with all FDA-approved radiotracers.